Ehrlichiosis and Anaplasmosis: An Update

Pedro Paulo V P Diniz; Daniel Moura de Aguiar

doi:10.1016/j.cvsm.2022.07.002

Ehrlichiosis and Anaplasmosis: An Update

Vet Clin North Am Small Anim Pract. 2022 Nov;52(6):1225-1266. doi: 10.1016/j.cvsm.2022.07.002.

Authors

Pedro Paulo V P Diniz¹, Daniel Moura de Aguiar²

Affiliations

¹ Western University of Health Sciences, College of Veterinary Medicine, 309 East 2nd Street, Pomona, CA 91766, USA. Electronic address: pdiniz@westernu.edu.
² Laboratory of Virology and Rickettsiosis, Federal University of Mato Grosso State - UFMT, Avenida Fernando Correa da Costa, 2367, Cuiabá, Mato Grosso, Brazil.

PMID: 36336419
DOI: 10.1016/j.cvsm.2022.07.002

Abstract

Canine ehrlichiosis and anaplasmosis are zoonotic tick-borne diseases with broad distribution. Advances in diagnostics have enhanced our understanding of the species of rickettsial organisms involved, their expanding geographic distribution, and their impact on the health of dogs, cats, and people. While clinical remission can be achieved with appropriate antimicrobial therapy, optimal treatment modalities for the elimination of infection remain somewhat uncertain. Protection through vaccines for ehrlichiosis or anaplasmosis remains elusive. This review provides practicing veterinarians with the most current information about the transmission, diagnosis, and management of ehrlichiosis and anaplasmosis in dogs and cats.

Keywords: Anaplasma; Cat; Dog; Doxycycline; Ehrlichia; PCR; Serology; Zoonosis.

Publication types

Review

MeSH terms

Anaplasmosis* / diagnosis
Anaplasmosis* / drug therapy
Anaplasmosis* / epidemiology
Animals
Cat Diseases* / diagnosis
Cat Diseases* / therapy
Cats
Dog Diseases* / diagnosis
Dog Diseases* / epidemiology
Dog Diseases* / therapy
Dogs
Ehrlichia
Ehrlichiosis* / diagnosis
Ehrlichiosis* / drug therapy
Ehrlichiosis* / epidemiology
Ehrlichiosis* / veterinary